Mustang Bio (MBIO) Revenue (2018)
Mustang Bio's (MBIO) quarterly Revenue came in at $50000.0 in Q1 2018.
Powered by 
Analysis
Mustang Bio (MBIO) Revenue (2018) Analysis & Trends
Mustang Bio (MBIO) has reported Revenue for 1 consecutive years, with $50000.0 the latest figure, recorded in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | 119.22 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | 10.18 Mn |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 99.31 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | 387.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 5.84 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | 490,000.00 |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 54.98 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 401.25 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 77.46 Mn |
| 10 | Mustang Bio | 3.50 Mn | 3.50 Mn | - | - |